Morishita Jintan Co., Ltd. (4524) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Morishita Jintan Co., Ltd. (4524:JPX), powered by AI.

Current Price
¥2,153
P/E Ratio
16.1
Market Cap
8.8B
Sector
Healthcare
What is the Morishita Jintan Co., Ltd. stock price forecast?

Morishita Jintan Co., Ltd. is currently trading at ¥2,153. View real-time AI analysis on Alpha Lenz.

What is Morishita Jintan Co., Ltd. insider trading activity?

View the latest insider trading data for Morishita Jintan Co., Ltd. on Alpha Lenz.

What is Morishita Jintan Co., Ltd.'s P/E ratio?

Morishita Jintan Co., Ltd.'s P/E ratio is 16.1.

Morishita Jintan Co., Ltd.

JPX · 4524
¥2,153+1(+0.05%)Market closedJPX regular session 09:00–15:00 JST
Ask about Morishita Jintan Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Morishita Jintan Co., Ltd. trades at a P/E of 16.1 (fair value) with modest ROE of 4.5%. 3Y revenue CAGR of 10.1% highlights clear growth momentum.

Ask for details

Company Overview

Morishita Jintan Co., Ltd. is a renowned Japanese company primarily involved in the production and distribution of pharmaceuticals and health-related products. Established in 1893, it carved a niche with its innovative herbal medicine and encapsulated products. Over the years, Morishita Jintan has expanded its offerings to include dietary supplements, oral hygiene products, and environmental materials. The company is particularly noted for its encapsulation technology, which enhances the delivery and absorption of active ingredients. This technology has significant implications not only in pharmaceuticals but also across food and cosmetics industries. Morishita Jintan Co., Ltd. plays a crucial role in the health and wellness sector, catering to a diverse consumer base both domestically in Japan and internationally. Its long-standing reputation and focus on quality make it a key player in the market, constantly striving to contribute to healthy lifestyles through its innovative solutions.

CEOMr. Yuji Morishita
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees356

Company Statistics

FY 2025

Profile

¥8,803,617,000Market Cap
¥12,766,000,000Revenue
0.00Shares Out
356Employees

Margins

46.79%Gross
11.39%EBITDA
6.34%Operating
6.05%Pre-Tax
4.28%Net

Valuation

16.09P/E
0.72P/B
0.69EV/Sales
5.70EV/EBITDA
-880.36P/FCF

Growth (CAGR)

10.11%Rev 3Yr
5.47%Rev 5Yr
38.58%Op Inc 3Yr
12.05%Op Inc 5Yr
24.57%Net Inc 3Yr
11.18%Net Inc 5Yr

Returns

3.12%ROA
4.50%ROE
4.45%ROIC

Financial Health

¥1,940,000,000Cash & Cash Equivalents
¥3,804,000,000Net Debt
47.27%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Morishita Jintan Co., Ltd. (ticker: 4524) is a company listed on JPX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 356 employees. Market cap is $8.8B.

The current price is 2,153 with a P/E ratio of 16.09x and P/B of 0.72x.

ROE is 4.50% and operating margin is 6.34%. Annual revenue is $12.8B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Morishita Jintan Co., Ltd. (4524) Stock Forecast 2026 ¥2,153 — Price, Financials & Analyst Targets | Alpha Lenz